Business2 weeks ago
Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer’s disease to late-stage testing despite disappointing mid-stage...